%PDF-1.3
%
13 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
11 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
22 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
12 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
10 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
15 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
17 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
16 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
20 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
14 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
18 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
21 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
19 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
24 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2016-11-23T07:55:21-08:00
2016-06-04T07:14:57+05:30
application/pdf
LRB-2015-0054-ver9-Li_2P 1..7
uuid:59ba922c-1725-42c3-896c-564e65d03742
uuid:d728f703-e023-49ea-a367-22bd33e9765b
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS**T0T0 Bih]9D. qaj
endstream
endobj
29 0 obj
<>stream
x+ |
endstream
endobj
30 0 obj
<>stream
xS**T0T0 Bih]D. r^j
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
33 0 obj
<>stream
x+ |
endstream
endobj
34 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
35 0 obj
<>stream
x+ |
endstream
endobj
36 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
37 0 obj
<>stream
x+ |
endstream
endobj
38 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
40 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(article,)-314.5(we)-309.5(retrospectively)-309.4(compare)-311.9(the)-309.9(therapeutic)-316.6(effect)-309.7(in)]TJ
0 -1.1174 TD
[(80)-393.9(patients)-397.2(treated)-403.1(by)-393.9(HBT)-392.3(to)-399.7(26)-393.9(patients)-397.2(treated)-397.3(by)-393.9(SBT)]TJ
0 -1.1116 TD
[(alone)-319(between)-317.5(2005)-309.7(and)-315.5(2013)-315.4(with)-316.6(chronic)-315.4(lymphedema)-316.6(of)]TJ
T*
[(the)-281.1(extremities)-287.8(associated)-286.2(with)-282(DLA.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 664.951 Tm
[(Patients)-334.4(and)-338.2(Methods)]TJ
/F11 1 Tf
0 -1.8336 TD
[(Ethical)-338.9(aspects)]TJ
/F6 1 Tf
9.843 0 0 9.843 72 632.0692 Tm
[(This)-230.2(study)-224.3(was)-229.8(approved)-230(by)-232.6(the)-223.5(local)-232.7(Ethics)-227.9(Committee)-235(of)]TJ
-1.0137 -1.1116 TD
[(the)-258(University.)-264.3(Written)-264.9(informed)-258.9(consent)-263.4(was)-258.6(obtained)-259.1(from)]TJ
T*
[(each)-221(subject)-223.2(before)-222(entrance)-220.9(into)-217.8(the)-223.5(study.)-216.2(The)-224.5(research)-220.6(was)]TJ
0 -1.1174 TD
[(conducted)-416.7(in)-417(accordance)-421.1(with)-420.2(the)-413.5(ethical)-420.5(standards)-415.1(of)-416.9(the)]TJ
0 -1.1116 TD
[(responsible)-429(committee)-425.2(on)-422.7(human)-428.4(experimentation)-426.1(and)-424.9(the)]TJ
T*
[(Helsinki)-281.8(Declaration)-288.7(of)-278.6(1975.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 549.9778 Tm
[(Inclusion)-336.7(criteria)]TJ
/F6 1 Tf
9.843 0 0 9.843 72 533.5369 Tm
[(Inclusion)-253(criteria)-260.3(was)-252.8(unilateral)-256.9(extremity)-255.7(lymphedema)-259(in)]TJ
-1.0137 -1.1116 TD
[(stages)-313.9(IIII)-310.6(as)-314.2(dened)-308.3(by)-313.2(the)-309.9(International)-312(Society)-315.4(of)-307.4(Lym-)]TJ
0 -1.1174 TD
[(phology)-497.4(\(ISL\))-496(classication,)]TJ
7.3823 0 0 6.5614 179.433 516.0188 Tm
(10,11)Tj
9.843 0 0 9.843 200.9196 511.5967 Tm
[(associated)-499.4(with)-495.1(an)-492.9(inci-)]TJ
-14.1113 -1.1116 TD
[(dence)-285.5(of)-278.6(DLA)-282.7(of)-278.6(greater)-287.7(than)-282.2(one)-280.9(episode)-280.7(per)-280.9(year.)]TJ
1.0137 -1.1116 TD
[(Patients)-362.5(were)-358.9(excluded)-358(if)-359.4(they)-362.8(had)-355.8(clinical)-364.2(or)-353.5(radiologic)]TJ
-1.0137 -1.1116 TD
[(evidence)-382.2(of)-382.3(ongoing)-376.5(malignancy,)-382.3(or)-382.3(had)-378.8(an)-377.7(associated)-384.2(co-)]TJ
0 -1.1174 TD
[(morbidity)-380.1(that)-380.2(would)-380.9(preclude)-386.8(daily)-375.5(treatment)-383.6(and)-384.6(follow-)]TJ
0 -1.1116 TD
[(up.)-247.5(In)-244.1(addition,)-244.2(those)-248.5(patients)-247.5(with)-247.4(a)-249.9(contraindication)-247.5(to)-244.2(heat)]TJ
T*
[(and)-350(compression)-349.5(bandage)-351(therapy,)-347.6(such)-345.2(as)-348.7(untreated)-353.5(infec-)]TJ
0 -1.1174 TD
[(tion)-194.7(or)-192.2(vessel)-193(thrombosis,)-194.1(as)-193.2(well)-196.8(as)-193.2(those)-190.9(who)-194.2(were)-197.6(unable)-193.4(to)]TJ
0 -1.1116 TD
[(provide)-285.4(consent)-286.4(or)-284.4(adhere)-286.5(to)-284.6(the)-281.1(protocol)-286.7(or)-284.4(had)-286.7(extremities)]TJ
T*
[(of)-261.4(such)-264.6(huge)-259(size)-265.8(as)-262.4(to)-261.5(preclude)-265.8(their)-260.3(placement)-269.5(in)-261.5(the)-263.8(cabin)]TJ
0 -1.1174 TD
[(of)-278.6(our)-285.5(machine,)-280.9(were)-284(excluded)-283.1(from)-282(the)-281.1(study.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 374.7401 Tm
(Patients)Tj
/F6 1 Tf
9.843 0 0 9.843 72 358.2991 Tm
[(One)-339.4(hundred)-342.9(and)-344.3(six)-343.1(patients)-345.4(were)-341.6(enrolled)-345.4(in)-342.1(our)-337.3(study)]TJ
-1.0137 -1.1174 TD
[(\(Table)-367.3(1\),)-368.5(with)-368.4(29)-365.1(being)-363.9(male)-370.9(and)-367.3(77)-365.1(female.)-366.2(Thirty)-365.1(eight)]TJ
0 -1.1116 TD
[(were)-358.9(diagnosed)-357.8(with)-351.1(upper)-358(extremity)-359.4(lymphedema,)-354.6(and)-355.8(68)]TJ
T*
[(with)-316.6(lower)-312.9(extremity)-319.1(lymphedema.)-320(Twenty)-315.2(four)-315.4(were)-312.8(diag-)]TJ
T*
[(nosed)-190.8(as)-181.7(having)-192.2(primary)-188.7(lymphedema,)-187.6(and)-188.8(82)-186.5(with)-184.1(secondary)]TJ
0 -1.1174 TD
[(lymphedema.)-383.4(The)-380(mean)-382.3(age)-380(in)-376.7(our)-377.7(series)-383(was)-379.5(51.34)-376.5(years)]TJ
0 -1.1116 TD
[(\(range)-394.8(1480\))-392.5(and)-390.4(the)-390.5(mean)-393.9(duration)-390.3(of)-393.8(lymphedema)-391.5(was)]TJ
T*
[(18.89)-318.9(years)-324.4(\(range,)-317.6(167\).)-319.9(These)-325.6(106)-314.3(patients)-322.4(were)-324.4(divided)]TJ
0 -1.1174 TD
[(into)-309.9(two)-303.8(groups:)-307.1(group)-305(1)-306.4(\(80)-308.5(patients\))-311.9(was)-304.6(treated)-310.9(by)-307.5(HBT,)]TJ
0 -1.1116 TD
[(whereas)-259.5(group)-258.9(2)-254.5(\(26)-250.9(patients\))-260.1(was)-258.6(treated)-259.1(by)-255.6(SBT)-253(\(Table)-257.9(1\).)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 725.7825 Tm
[(Therapeutic)-337.8(intervention)]TJ
/F2 1 Tf
1.1128 -1.6123 TD
[(Group)-366.2(1.)]TJ
/F6 1 Tf
9.843 0 0 9.843 367.5967 711.3258 Tm
[(Patients)-316.4(received)-313.1(HBT)-317.4(at)-308.8(The)-310.9(Shanghai)-316.4(Ninth)]TJ
-5.5408 -1.1116 TD
[(Peoples)-391(Hospital,)-383.1(China.)-385.6(We)-385.8(used)-379.7(a)-388.2(specialized)-386.7(cabin)-382.3(for)]TJ
0 -1.1174 TD
[(producing)-604.4(far)-603.4(infrared)-604.4(rays)-604.4(\(31000)]TJ
/F12 1 Tf
15.9313 0 TD
(l)Tj
/F6 1 Tf
.5529 0 TD
[(m)-601.3(electromagnetic)]TJ
-16.4843 -1.1116 TD
[(waves\))-360.9(\(Fig.)-353.4(1\).)-356.9(This)-351.1(far)-355.7(infrared)-362.5(ray)-350(machine)-358.1(contains)-356.8(six)]TJ
T*
[(far)-303.9(infrared)-304.9(ray)-303.9(tubes)-300.4(for)-302.7(producing)-304.9(heat)-300.6(and)-304(a)-301.8(regulator)-300.4(for)]TJ
T*
[(controlling)-440(the)-442.3(temperature.)-442.1(The)-437.6(patients)-443.3(were)-439.5(treated)-437.6(for)]TJ
0 -1.1174 TD
[(2)-254.5(hours)-252.9(with)-253.2(the)-252.3(far)-252.1(infrared)-258.8(ray)-252.1(machine)-254.5(at)-251.2(a)-255.7(temperature)-254.3(of)]TJ
0 -1.1116 TD
(42)Tj
/F8 1 Tf
1.0022 0 TD
()Tj
/F6 1 Tf
.3974 0 TD
[(C)-284.3(each)-290.1(day)-286.7(for)-285.5(4)-283.3(weeks)-290.7(\(5)-284.4(working)-290.9(days)-281.8(per)-286.7(week\))-290.9(for)-285.5(a)]TJ
-1.3996 -1.1116 TD
[(total)-283.5(of)-284.4(20)-278.7(sessions)-280(\(one)-282(course\).)]TJ
1.0137 -1.1174 TD
[(After)-307.1(each)-301.6(session,)-305.6(a)-301.8(trained)-304(therapist)-306.1(would)-306(bandage)-305(the)]TJ
-1.0137 -1.1116 TD
[(patients)-260.1(upper)-254.3(or)-255.6(lower)-255.3(extremity)-261.5(using)-253.1(elastic)-259.1(compression)]TJ
T*
[(banda)-7.8(ges)-568.7(\(Hartmann,)-576.5(Germany\))-577.6(from)-575.8(the)-574.8(hand/foot)-575.8(and)]TJ
0 -1.1174 TD
[(working)-446.4(proximally)-445.7(to)-440.1(the)-448.1(shoulder/thigh.)-440.8(Bandages)-450.9(were)]TJ
0 -1.1116 TD
[(worn)-287.5(for)-285.5(the)-281.1(intervening)-291.3(22)-278.7(hours.)-285.2(Patients)-287.6(were)-284(also)-287.7(taught)]TJ
T*
[(self-bandaging)-318.4(techniques)-314.1(to)-307.6(allow)-313.1(for)-308.5(maintenance)-313.2(of)-313.2(ban-)]TJ
T*
[(daging)-307.4(over)-299.3(weekends)-306.7(and)-298.2(to)-301.8(facilitate)-304.3(bathing.)-306.3(All)-298.2(patients)]TJ
0 -1.1174 TD
[(received)-578(advice)-574.7(concerning)-573.3(skin)-568.8(care,)-570(exercise,)-575.5(and)-574.7(the)]TJ
0 -1.1116 TD
[(maintenance)-290.1(of)-278.6(a)-284.5(healthy)-281(body)-280.9(weight.)]TJ
/F2 1 Tf
8.9663 0 0 8.9663 323.0361 502.4692 Tm
[(Group)-353.5(2.)]TJ
/F6 1 Tf
9.843 0 0 9.843 367.4834 502.4692 Tm
[(Patients)-299.2(only)-292.5(received)-301.5(SBT)-299.1(in)-296.1(Shanghai)-299.1(Ninth)]TJ
-5.5293 -1.1116 TD
[(Peoples)-488.9(Hospital.)-486.8(This)-483.6(intervention)-488.3(was)-483.2(continued)-490.6(for)-481.3(4)]TJ
T*
[(weeks)-331.1(\(5)-318.9(working)-325.5(days)-327.9(per)-321.2(week\))-325.5(for)-325.8(a)-319(total)-329.6(of)-319(20)-324.7(sessions)]TJ
T*
[(\(one)-212.9(course\).)-209(Bandages)-209(were)-214.9(worn)-206.8(for)-204.8(the)-211.9(whole)-209.3(24)-203.8(hours)-212.6(per)]TJ
0 -1.1174 TD
[(day,)-244(and)-246.4(patients)-241.7(were)-249.5(also)-241.6(taught)-244.2(self-bandaging)-249.3(techniques)]TJ
0 -1.1116 TD
[(to)-359.4(allow)-359.1(for)-354.6(maintenance)-359.3(of)-353.5(bandaging)-358(over)-356.9(weekends)-364.3(and)]TJ
T*
[(facilitate)-442.5(bathing.)-433(All)-436.4(patients)-437.5(received)-439.8(advice)-436.4(concerning)]TJ
0 -1.1174 TD
[(skin)-355.7(care,)-351.1(exercise,)-356.6(and)-350(the)-355.9(maintenance)-353.5(of)-353.5(a)-347.8(healthy)-355.9(body)]TJ
0 -1.1116 TD
(weight.)Tj
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 392.3148 Tm
(Follow-up)Tj
/F6 1 Tf
9.843 0 0 9.843 323.0361 375.8739 Tm
[(At)-210.6(follow-up,)-204.5(these)-209.4(factors)-211.5(were)-209.2(recorded:)-215.1(1\))-203.8(Frequency)-209(of)]TJ
-1.0137 -1.1174 TD
[(DLA:)-272.4(The)-270.6(frequency)-272.5(of)-267.1(DLA)-271.2(episodes)-270.1(occurring)-271.5(per)-275.1(year)-265.9(in)]TJ
0 -1.1116 TD
[(the)-367.5(patients)-368.4(included)-368.5(in)-365.2(our)-360.4(study)-368.3(was)-368(recorded.)-367(DLA)-363.3(was)]TJ
T*
[(diagnosed)-300.2(by)-290.2(clinicians)-297.1(and)-292.4(the)-298.3(symptoms)-293.2(and)-292.4(signs)-293.2(clearly)]TJ
0 -1.1174 TD
[(documented)-459.4(in)-457.3(the)-453.8(medical)-456.2(records.)-456.7(2\))-451.4(Subjective)-458.2(patient)]TJ
0 -1.1116 TD
[(feedback:)-389(Subjective)-389.1(patient)-384.8(reporting)-385.7(after)-388(treatment)-389.4(con-)]TJ
T*
[(cerning)-298.1(outcomes)-294.5(such)-293.4(as)-291.2(pain,)-291.4(functionality,)-297.2(and)-292.4(quality)-291.5(of)]TJ
T*
-.0217 Tc
[(l)-5.6(i).1(f)-5.5(e)-196.7(\()-5.5(e)-.9(va)-6.7(lua)-6.7(t).1(ed)-201.3(by)-201.3(a)-202.5(que)-6.7(sti)-5.6(o).2(n)-5.5(n).2(ai)-5.6(re\))-201.3(w)-.6(e)-6.7(r).3(e)-202.5(obt)-5.6(ain)-5.5(e)-.9(d)-201.3(\().3(F)-5.4(i).1(g.)-203.7(2\).)]TJ
7.3823 0 0 6.5614 526.5637 303.5338 Tm
-.0246 Tc
(16,17)Tj
9.843 0 0 9.843 544.1951 299.1685 Tm
-.0219 Tc
(3\))Tj
ET
62.022 217.02 239.131 .22676 re
f
62.022 56.976 239.131 .28348 re
f
62.022 198.312 239.131 .22682 re
f
BT
/F10 1 Tf
9.845 0 0 9.845 102.7275 222.6897 Tm
0 Tc
(Table)Tj
/F6 1 Tf
3.0002 0 TD
(1.)Tj
/F10 1 Tf
1.2496 0 TD
[(Population)-335.4(Demographics)]TJ
/F7 1 Tf
-8.3844 -1.8427 TD
[(Items)-10550.8(Group)-333.8(1)-3726.8(Group)-333.8(2)]TJ
/F6 1 Tf
0 -1.9003 TD
[(Age)-10076.7(52.11)]TJ
/F8 1 Tf
14.1603 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
[(18.28)-1769.4(50.00)]TJ
/F8 1 Tf
6.4381 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
(18.94)Tj
-22.0379 -1.0077 TD
[(Years)-336.2(with)-333.4(lymphedema)-2031.4(10.25)]TJ
/F8 1 Tf
14.4079 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
[(9.16)-2275.2(11.30)]TJ
/F8 1 Tf
6.4438 0 TD
()Tj
/F6 1 Tf
.7141 0 TD
(6.73)Tj
-22.2856 -1.0135 TD
[(Sex\(female\))-9034.6(57)-6157.9(20)]TJ
T*
[(Sex\(male\))-9814.6(23)-6658.9(6)]TJ
/F7 1 Tf
1.002 -1.3129 TD
[(Lymphedema)-337.3(etiology)]TJ
/F6 1 Tf
-1.002 -1.0135 TD
[(Primary)-337.5(lymphedema)-5187.1(17)-6658.9(7)]TJ
T*
[(Venous)-336(insufciency)-5877.6(4)-6657.9(1)]TJ
0 -1.0077 TD
[(Breast)-337.5(cancer)-8418.1(12)-6658.9(7)]TJ
0 -1.0135 TD
[(Cervical)-335.3(cancer)-7577.4(17)-6658.9(5)]TJ
T*
[(Ovarian)-338.5(cancer)-8251.1(3)-6657.9(3)]TJ
T*
[(Trauma)-11314.6(9)-6657.9(1)]TJ
0 -1.0077 TD
[(Infection)-10313.6(15)-6658.9(2)]TJ
0 -1.0135 TD
[(Other)-12157.6(3)-6657.9(0)]TJ
ET
q
1 i
313.795 275.244 m
551.452 275.244 l
551.452 93.26 l
313.795 93.26 l
W n
q
237.657 0 0 181.984 313.795 93.26 cm
/Im1 Do
Q
Q
BT
/F9 1 Tf
9.845 0 0 9.845 313.0582 76.4787 Tm
[(FIG.)-417.4(1.)]TJ
/F6 1 Tf
4.198 0 TD
[(A)-416.4(far)-418.8(infrared)-413.5(ray)-418.8(producing)-413.3(machine,)-418.3(made)-416.3(by)]TJ
-4.198 -1.0077 TD
[(the)-257.7(Ninth)-253.7(Peoples)-257.7(Hospital)-252.1(in)-255.5(Shanghai.)-255.5(Patients)-258.1(place)-256.3(their)]TJ
0 -1.0135 TD
[(extremities)-338.6(in)-336.2(its)-331.4(cabin)-335.7(for)-337(heating)-332.1(treatment.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(2)Tj
50.2102 0 TD
[(LI)-331.6(ET)-338.7(AL.)]TJ
ET
endstream
endobj
43 0 obj
<>stream
Adobe d C
{
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? WP(6tT^آ4']S'\Gþ*()f7_hX~eq|y:kӞ1zHudK >0qڣc[3P(Pe+n ܜ^Pwe,SrvԨ'~$q=5_ކ~$PJW3S_bb,O.GP,Xxx\b1gfcB߀ƵvQc1ƇW9۶,XCKv阀-`_aPG=(: I{_aOv=H#9dbkӶj(N-bZ+UoF
Cjj1Ei+7CZJM?mך/:T# 5?+u~so:bv?.q~j' YZZ53$ yH
OoRǤFrc)rc[#YA醧w XB+ڹďrT^-mmJ}[/ '姘c?' uDD$pߔVnu1 Q¹lrfHJ`V N(aoӦ N(DԞ=1v
(Z!/Rv '锠#]Ҙ~,MI錘~IO\%D' 530OTG/
Ly"ħ9;P;tĥޞ1Tvrص TM˖rs3!eA?@,zv#P8d1 iu֡8{d/>~zVIʗʾNOHH\Mu`(`+ 0 0